NCT02135406View on ClinicalTrials.gov

CART-19 for Multiple Myeloma

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

January 18, 2018

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

CART-19 T cells

Trial Locations (1)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT02135406 - CART-19 for Multiple Myeloma | Biotech Hunter | Biotech Hunter